| Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update KR Crews, A Gaedigk, HM Dunnenberger, JS Leeder, TE Klein, ... Clinical Pharmacology & Therapeutics 95 (4), 376-382, 2014 | 700 | 2014 |
| The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin‐Induced Myopathy: 2014 Update LB Ramsey, SG Johnson, KE Caudle, CE Haidar, D Voora, RA Wilke, ... Clinical Pharmacology & Therapeutics 96 (4), 423-428, 2014 | 456 | 2014 |
| Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and … KE Caudle, K Sangkuhl, M Whirl‐Carrillo, JJ Swen, CE Haidar, TE Klein, ... Clinical and translational science 13 (1), 116-124, 2020 | 425 | 2020 |
| Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy KR Crews, AA Monte, R Huddart, KE Caudle, ED Kharasch, A Gaedigk, ... Clinical Pharmacology & Therapeutics 110 (4), 888-896, 2021 | 276 | 2021 |
| PG4KDS: a model for the clinical implementation of pre‐emptive pharmacogenetics JM Hoffman, CE Haidar, MR Wilkinson, KR Crews, DK Baker, ... American Journal of Medical Genetics Part C: Seminars in Medical Genetics …, 2014 | 261 | 2014 |
| Development and use of active clinical decision support for preemptive pharmacogenomics GC Bell, KR Crews, MR Wilkinson, CE Haidar, JK Hicks, DK Baker, ... Journal of the American Medical Informatics Association 21 (e1), e93-e99, 2014 | 229 | 2014 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing RS Gammal, MH Court, CE Haidar, OF Iwuchukwu, AH Gaur, M Alvarellos, ... Clinical Pharmacology & Therapeutics 99 (4), 363-369, 2016 | 181 | 2016 |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype MV Relling, EM McDonagh, T Chang, KE Caudle, HL McLeod, CE Haidar, ... Clinical Pharmacology & Therapeutics 96 (2), 169-174, 2014 | 139 | 2014 |
| PharmGKB summary: very important pharmacogene information for UGT1A1 JM Barbarino, CE Haidar, TE Klein, RB Altman Pharmacogenetics and genomics 24 (3), 177-183, 2014 | 138 | 2014 |
| Integrating pharmacogenomics into electronic health records with clinical decision support JK Hicks, HM Dunnenberger, KF Gumpper, CE Haidar, JM Hoffman American journal of health-system pharmacy 73 (23), 1967-1976, 2016 | 136 | 2016 |
| The pharmacogenomics research network translational pharmacogenetics program: outcomes and metrics of pharmacogenetic implementations across diverse healthcare systems JA Luzum, RE Pakyz, AR Elsey, CE Haidar, JF Peterson, M Whirl‐Carrillo, ... Clinical Pharmacology & Therapeutics 102 (3), 502-510, 2017 | 128 | 2017 |
| A Clinician-Driven Automated System for Integration of Pharmacogenetic Interpretations Into an Electronic Medical Record JK Hicks, KR Crews, JM Hoffman, NM Kornegay, MR Wilkinson, R Lorier, ... Clinical Pharmacology & Therapeutics, 2012 | 112 | 2012 |
| Pharmacogenetics for safe codeine use in sickle cell disease RS Gammal, KR Crews, CE Haidar, JM Hoffman, DK Baker, PJ Barker, ... Pediatrics 138 (1), 2016 | 83 | 2016 |
| Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers NJ Keeling, MM Rosenthal, D West-Strum, AS Patel, CE Haidar, ... Genetics in Medicine 21 (5), 1224-1232, 2019 | 71 | 2019 |
| Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes JK Hicks, KR Crews, P Flynn, CE Haidar, CC Daniels, W Yang, ... Pharmacogenomics 15 (8), 1065-1078, 2014 | 68 | 2014 |
| Clinical Pharmacogenetics Implementation Consortium Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update KR Crews, A Gaedigk, HM Dunnenberger, JS Leeder, TE Klein, ... Clin Pharmacol Ther 95 (4), 376-382, 2014 | 64 | 2014 |
| Comparison of genome sequencing and clinical genotyping for pharmacogenes W Yang, G Wu, U Broeckel, CA Smith, V Turner, CE Haidar, S Wang, ... Clinical Pharmacology & Therapeutics 100 (4), 380-388, 2016 | 55 | 2016 |
| Drug interactions in childhood cancer C Haidar, S Jeha The Lancet Oncology 12 (1), 92-99, 2011 | 50 | 2011 |
| ASHP statement on the pharmacist’s role in clinical pharmacogenomics CE Haidar, N Petry, C Oxencis, JS Douglas, JM Hoffman American Journal of Health-System Pharmacy 79 (8), 704-707, 2022 | 49 | 2022 |
| Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype RS Gammal, M Pirmohamed, AA Somogyi, SA Morris, CM Formea, ... Clinical Pharmacology & Therapeutics 113 (5), 973-985, 2023 | 20 | 2023 |
Mary V. RellingSt. Jude Children's Research HospitalVerified email at stjude.org
